尽管整个行业对大麻可能重新分类持乐观态度，Tilray股价在技术信号混合下下跌5.3%。 Tilray shares dropped 5.3% amid mixed technical signals, despite sector-wide optimism over potential marijuana reclassification.

Tilray Brands(TLRY)股份在星期一下跌5.27%至11.51美元, 尽管交易量猛增39%, Tilray Brands (TLRY) shares fell 5.27% to $11.51 on Monday, reversing recent gains despite a 39% surge in trading volume. 上周,大麻部门聚集一堂,猜测特朗普总统可能将大麻重新归类为附表三所列药物,这有可能放宽联邦限制。 The cannabis sector rallied last week on speculation that President Trump may reclassify marijuana as a Schedule III drug, potentially easing federal restrictions. 尽管Tilray仍低于50日和100日移动平均线,但技术指标显示出混合信号,中性势头和持续的看MACD势头. While Tilray remains below its 50-day and 100-day moving averages, technical indicators show mixed signals with neutral momentum and ongoing bullish MACD momentum. 股票有一个一致的“等待”评级,平均价格目标为$20.00。 The stock has a consensus "Hold" rating with a $20.00 average price target.